黄芪注射液治疗糖尿病肾病的疗效观察与分析  

The Clinical Therapeutic Effect of Astragalus Mongholicus(AM) in Treatment of Diabetic Nephropathy

作　　者：郑强[1] 尉冬英[1] 李雪梅[1] 夏映苹[1] 

机构地区：[1]成都市第六人民医院,四川成都610051

出　　处：《华西医学》2009年第9期2319-2320,共2页West China Medical Journal

摘　　要：目的:观察黄芪注射液治疗糖尿病肾病的临床疗效。方法:将116例糖尿病肾病患者随机分为治疗组和对照组,治疗组在对照组的基础上同时使用黄芪注射液,观察治疗后4周24小时尿蛋白定量、血肌酐、尿素氮、血尿β2微球蛋白、甘油三酯、总胆固醇、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇、血尿酸等变化。结果:治疗组治疗后24小时尿蛋白定量、血尿酸均有不同程度的改善,与治疗前比较P<0.05,治疗组与对照组比较P<0.05。而血尿β2微球蛋白、血胆固醇无明显变化。结论:黄芪注射液对糖尿病肾病有较好的疗效。Abstract： Objective： To observe the clinical therapeutic effect of AM on diabetic nephropathy. Methods： One hun dred and sixteen patients of diabetic nephropatby were divided into control group （58 cases, traditional therapy） and treatment group （58 cases, traditional therapy-＋- AM） randomly. After 4 weeks treatment, Proteinuria, blood132-MG , urine^2 MG.creatinine. blooduria nitrogen,trglceride.total cholesterol,uric acid were determined in all the patients before and after the treatment. Obvious reduction in proteinuria and blood uric acid of the treatment group was Observed （P〈0.05）. And no obvious change in blood β2-MG, urine β2-MG and cholesterol between the treatment group and the control. Conclusion： AM is a efficient treatment agent for diabetic nephropathy.

关 键 词：黄芪 糖尿病肾病 

分 类 号：R259[医药卫生—中西医结合]